HSPE1-MOB4: A Drug Target / Disease Biomarker (G100529241)

Target Name: HSPE1-MOB4

NCBI ID: G100529241

HSPE1-MOB4

Other Name(s): 10 kDa heat shock protein, mitochondrial | HSPE1-PHOCN | HSPE1-MOB4 readthrough

HSPE1-MOB4: A Drug Target / Disease Biomarker

HSPE1-MOB4 is a protein that is expressed in various tissues throughout the body, including the brain, heart, lungs, and kidneys. It is a heat shock protein (HSP) that is involved in the regulation of protein synthesis and stability. HSPE1-MOB4 has been identified as a potential drug target (or biomarker) due to its involvement in a variety of cellular processes that are important for human health and disease.

One of the key functions of HSPE1-MOB4 is its role in the regulation of protein synthesis. HSPE1-MOB4 is known to play a role in the process of translation, which is the process by which RNA molecules are translated into proteins. This process is critical for the development and growth of new tissues and organs, and it is also important for the regulation of immune responses and inflammation.

Another function of HSPE1-MOB4 is its role in the regulation of protein stability. HSPE1-MOB4 is involved in the process of protein folding, which is the process by which proteins are shaped into their three-dimensional structure and determine their function. This process is important for the regulation of a wide range of cellular processes, including cell signaling, DNA replication, and metabolism.

In addition to its role in protein synthesis and stability, HSPE1-MOB4 is also involved in the regulation of cellular processes that are important for brain function. HSPE1-MOB4 has been shown to play a role in the regulation of neurotransmitter release from neurons, which is important for the proper functioning of the nervous system.

HSPE1-MOB4 is also involved in the regulation of inflammation. HSPE1-MOB4 has been shown to play a role in the regulation of the immune response, which is important for the fight against infection and disease.

Due to its involvement in a wide range of cellular processes, HSPE1-MOB4 has been identified as a potential drug target. Studies have shown that HSPE1-MOB4 can be targeted with small molecules, such as rapamycin, which is a drug that is used to prevent the growth of cancer cells. Rapamycin has been shown to inhibit the activity of HSPE1-MOB4, which suggests that it may be an effective treatment for a variety of diseases.

In conclusion, HSPE1-MOB4 is a protein that is involved in a wide range of cellular processes that are important for human health and disease. As a potential drug target, HSPE1-MOB4 has the potential to be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of HSPE1-MOB4 in cellular processes and its potential as a drug target.

Protein Name: HSPE1-MOB4 Readthrough

The "HSPE1-MOB4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSPE1-MOB4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets